The efficacy of first-line gefitinib therapy was evaluated in 25 patients with EGFR-mutated advanced AC.

Conclusions: Chemo-C-ion RT for locally advanced AC of the uterine cervix is associated with a long-term survival benefit.

We evaluated the long-term significance of concurrent weekly cisplatin and C-ion RT for locally advanced AC of the uterine cervix.